8-K: NovAccess Global Secures $117,000 Loan, Acquires Stake in UK Healthcare Marketing Firm

NovAccess Global Inc. has entered into a securities purchase agreement for a $117,000 loan and acquired an 18.6% stake in Fendix Media Limited, a UK healthcare marketing firm.

Summary

• NovAccess Global Inc. secured a $117,000 loan from AJB Capital Investments, LLC, with a 10% original issuance discount, resulting in net proceeds of $105,300.
• The loan carries a 12% annual interest rate and is due on November 13, 2024.
• The loan must be repaid from the proceeds of an offering exceeding $5.0 million in connection with uplisting to a national securities exchange.
• The company issued warrants to AJB to purchase 10 million shares of common stock at $0.0001 per share.
• NovAccess acquired an 18.6% ownership interest in Fendix Media Limited in exchange for 14,795,455 newly-issued unregistered shares of NovAccess common stock.
• Fendix is a healthcare marketing communications firm and a digital engagement partner with the UK's National Health Service (NHS).
• The Fendix transaction is a preliminary step in completing a previously disclosed investment by David Sumner.

Sentiment

Score: 4

Explanation: The document indicates a high level of financial risk due to the unfavorable loan terms and potential dilution. While the acquisition of Fendix is a positive step, the overall financial structure raises concerns.

Positives

• The loan from AJB Capital Investments allowed NovAccess to retire all of its debt with 1800 Lending.
• The acquisition of a stake in Fendix Media Limited provides NovAccess with a foothold in the UK healthcare marketing sector.
• The company has the option to prepay the loan at any time without penalty.
• The company may redeem 3 million warrants for $1.00 if the loan is repaid by August 13, 2024.

Negatives

• The loan has an original issuance discount of 10%, reducing the net proceeds.
• The loan agreement includes restrictions on selling assets and issuing additional debt.
• Failure to comply with loan covenants could result in an 18% default interest rate and other penalties.
• The company must repay the loan from proceeds of a future offering exceeding $5 million.
• The warrants issued to AJB could cause significant dilution to existing shareholders.

Risks

• Failure to make required payments or comply with loan covenants could trigger an event of default, leading to higher interest rates and potential conversion of debt to equity at a discount.
• The company's ability to repay the loan is contingent on a successful capital raise exceeding $5 million.
• The company may not be able to complete the Sumner Global transaction, which is subject to contingencies.
• The company is subject to restrictions on selling assets and issuing additional debt without AJB's approval.
• The issuance of warrants to AJB could lead to significant dilution of existing shareholders' equity.

Future Outlook

The company anticipates closing the Sumner Global transaction shortly, but there is no guarantee of completion. The company is also planning to uplist to a national securities exchange, which is tied to the repayment of the loan.

Industry Context

The acquisition of Fendix Media Limited aligns with a trend of healthcare companies seeking to enhance their digital marketing and communication capabilities, particularly in engaging with healthcare providers and patients. This move could position NovAccess to capitalize on the growing demand for digital health solutions.

Comparison to Industry Standards

• The loan terms, including the 10% discount and 12% interest rate, are relatively high, suggesting a higher risk profile compared to loans secured by more established companies.
• The warrant terms, with a very low exercise price of $0.0001, are highly favorable to the lender and could lead to significant dilution for existing shareholders.
• The acquisition of an 18.6% stake in Fendix for 14,795,455 shares of NovAccess stock is a common method for smaller companies to expand their reach, but the valuation of the stake is not explicitly stated.
• Compared to other healthcare marketing firms, Fendix's focus on digital engagement with the NHS is a niche market, which could provide a competitive advantage but also carries specific risks related to the UK healthcare system.

Stakeholder Impact

• Shareholders may experience dilution due to the issuance of warrants and shares.
• Creditors are impacted by the new loan and the retirement of previous debt.
• Employees may be affected by the company's financial situation and strategic direction.
• Customers may benefit from the company's expansion into the UK healthcare market.

Next Steps

• NovAccess needs to complete a capital raise exceeding $5 million to repay the loan.
• The company must file a Form S-1 by August 11, 2024, to register the shares for resale.
• The company needs to secure the listing of the shares on a national securities exchange.
• The company needs to complete the previously disclosed investment by Mr. Sumner.

Key Dates

Keywords

loan, acquisition, healthcare marketing, promissory note, warrants, debt, Fendix Media, AJB Capital Investments, capital raise, dilution